Videos Only OverviewThis symposium is designed to equip participants with the practical skills needed to enhance bedside patient management, apply innovative therapies effectively, and improve outcomes for patients with cardiovascular disease. Target AudienceThis activity is intended for physicians, nurses, and allied health professionals seeking a comprehensive, up-to-date review of disease mechanisms, diagnostic imaging, and expert management strategies for advanced cardiovascular disorders. Learning ObjectivesBy the end of this activity, participants should be able to: Explain the role of mechanical circulatory support in patients undergoing complex coronary intervention. Discuss novel stent platforms and the regulatory pathway to FDA approval. Develop a practical understanding of newer methods for plaque and calcium modification in coronary disease management. Compare surgical and percutaneous revascularization approaches in diabetic patients with complex coronary anatomy. Discuss the role of advanced imaging in cardiovascular disease management, including noninvasive imaging and high-resolution invasive coronary imaging such as OCT and IVUS. Describe the emerging role of mechanical left atrial appendage therapy, novel cerebral embolic protection devices, and adjunctive devices in structural heart disease management. Apply knowledge of radial-based and alternative vascular access approaches in cardiovascular therapy. Define the role of transcatheter and surgical therapies for patients with advanced aortic stenosis and aortic insufficiency. Discuss the role of transcatheter aortic valve replacement (TAVR) in patients with symptomatic moderate aortic stenosis. Describe catheter-based therapies for degenerative and functional mitral valve disease. Define emerging therapies for tricuspid and pulmonic valve disease. Review the most relevant clinical trials in coronary and structural heart disease that are shaping the near future of patient management. Review the most important recent trials in antiplatelet and antithrombotic therapy. S. No. Title Run Time 1 RCA ISR Management: Stent Boost and IVUS Inform DES Over DCB in Elderly Patient 43:51 2 Severe Valvular and Left Main CAD in Frail Patient: DK Crush PCI Strategy and Impella Support 43:52 3 Aortic Valve-in-Valve in Lotus Prosthesis: Technical Challenges and Key Lessons 53:48 4 Chronic Total Occlusion in RCA With Severe Obesity: Retrograde PCI Strategy and IVUS Guidance 36:34 5 Valve-in-Valve in Bicuspid AVR With Dacron Graft: Managing Fracture Limitations 22:59 6 CTO in RCA With Persistent Angina: Dual Guide Approach, IVUS Imaging, and Stenting 39:37 7 Presentation of a Case: Concomitant AF Ablation and LAA Occlusion 36:38 8 Severe MR in a 71-Year-Old: Valve-in-Valve-in-Ring Approach and Deployment Challenges 15:07 9 Women’s Heart Disease: Key Symptom Patterns and Early Detection 07:51 10 Examples of Escalating MCS in STEMI 10:35 11 Mechanical Complications of MI with Cardiogenic Shock: MitraClip Rescue 08:58 12 Vascular Access Challenges with MCS 10:00 13 Cut, Laser, Drill, and Shock 15:28 14 Massive Coronary Thrombosis- Treatment Algorithm and Creative Approaches 16:18 15 The Most Difficult Bifurcations- A Step-by-Step Algorithm 15:32 16 Approaches to Treating Complex Vein Graft Lesions (and the Native Vessels They Supply) 14:57 17 Mitral Transcatheter Edge-to-Edge Repair and Mandatory Mechanical Circulatory Support in Patients with Structural Shock 13:19 18 Novel Use of MitraClip to Treat Aortic Regurgitation 08:52 19 Intravascular Imaging is Now Class 1A in the European Guidelines: How Should US Interventionalists Respond? 22:43 20 Leaflet and Septal Modification during VIV TMVR: Rationale, Tips, and Tricks 15:28 21 Patient Selectiong for Tricuspid Therapies 09:35 22 Optimal TEE and 3D-ICE for Efficient and Effective T-TEER and TTVR 11:00 23 Transcatheter Mitral and Tricuspid Valve in Valve Best Practices 10:57 24 The Next Pillar of Heart Failure Management – the GLP-1 Agonist Phenomenon 13:51 25 Aortic Stenosis and Coronary Artery Disease: A Case Presentation 11:07 26 Coronary Evaluation and Stenting Pre-TAVR: Neither Cath nor PCI Frequently Necessary 08:37 27 Echo Gradients Are Flawed: All BE and SE Valves Do Well! 08:26 28 The Transcatheter Valve Journey: Present and Future 12:56 29 TAV-in-SAV and TAV-in-TAV: ABCDs of the Pre-Procedural Evaluation 13:01 30 Pre TAVR: Cath and Aggressive PCI for All? 11:59 31 The Data Are Clear: Self-Expanding Superior in Smaller Valves 11:35 32 Catheter Based Treatment for Valvular Heart Disease 03:44 33 Advances in Coronary Artery Disease Management 07:28 34 The Growing Field of Heart Failure Management 10:49 35 EVOQUE Tricuspid Valve Replacement 10:38 36 Strategies to Prevent Heart Disease 05:45 37 Managing Stable CAD in Severe Aortic Stenosis: Insights from NOTION and PCI Strategies 12:04 38 Mean Gradient with TEER: Why Higher Gradients Should be Tolerated 10:37 39 Optimal Pharmacologic Management Following LAAO 09:29 40 Left Atrial Appendage Occlusion: Current Advances, Remaining Challenges 10:15 41 M-TEER for Functional MR 13:59 42 Putting LAAO Clinical Trials in Perspective 10:34 43 How to Treat This 75-Year-Old with Severe Degenerative MR 02:10 44 Catheter-Based Therapies for Managing Aortic Insufficiencies 22:27 45 Spare the Blade – M-TEER Today! 04:50 46 The Data Are Favorable, but Can T-TEER Be Democratized? 12:37 47 Mitral Debate – No Way – Surgical Repair Rules Today! 11:58 48 Understanding FDA T-TEER Trials: Are There Enough Pros? 16:03 49 The Role of Transcatheter Tricuspid Valve Replacement: Unsuccessful TTEER with Giant Coaptaion Gap 10:27 50 CT Guidance in TMVR: Lessons Learned and Evolving Imaging Protocols 13:14 51 Tricuspid Regurgitation Impact on TAVR and M-TEER 10:35 52 Transcatheter Repair versus Mitral Valve Surgery for Secondary Mitral Regurgitation – Challenges in Trial Design and Interpretation of Outcomes 10:00 53 Should There Be Sex-Based Considerations in the Care of the AS Patient? 13:11 54 Will T-TEER Evolve Similar to M-TEER: an Operator’s Perpsective 11:27 55 Upstream Treatment of AS: Early TAVR, Evolved, TAVR Unload 19:37 56 Back to the Basics: Are Exercise Right Heart Catheterizations Mandatory? 05:37 57 CVD Jeopardy: Cath Lab & ICU Essentials – Arrhythmias, Shock, and Dissection Anticoagulation Pitfalls 17:30 58 The Evolution of HFrEF Therapies 13:52 59 The Emerging Role of Transcatheter Shunts 10:01 60 Evidence-Based Interventions Targeting Valvular Heart Disease in Heart Failure 15:13 61 ModulHeart, Aortix and the Novel Support Devices for Heart Management 15:08 62 Mea Culpa, Mea Culpa, Mea Maxima Culpa – STEMI Management 13:11 63 Left Atrial–Coronary Sinus Shunt Case: Salvaging a Disaster 11:50 64 The Heartbreak of Substance Use 15:23 65 Contemporary Management of STEMI/SHOCK 14:35 66 Cardiac Biomarkers in Acute and Chronic Care 13:17 67 Spontaneous Coronary Artery Dissection: Women & Heart Disease 14:18 68 Equipoise – What’s That – We Did That Study Already 11:07 69 Structural Heart Disease – Evaluation, Management and Postop Care 15:11 70 Transcatheter Repair versus Mitral Valve Surgery for Secondary Mitral Regurgitation VIDEO 71 Cryptogenic Stroke: What’s a PFO? 08:37 72 Surgical vs Transcatheter Approaches in Functional Mitral Regurgitation: Short and Long-Term Data 06:25 73 Failure to Cross: Success Begins with Failure 15:16 74 Left Main Disease: Management Challenges and PCI vs CABG Decision-Making 10:22 75 Making the Cath Lab a Safer Environment: Advances in Radiation Safety 12:55 76 Top Coronary Trials of the Last Year – 2025 Update 14:09 77 Oh, How I Wish That Wouldn’t Have Happened 19:03 78 Will There Be New Indications for the Use of DCB in Coronary Intervention? 13:22 79 CCTA in 2025 – Planning PCI 11:26 80 AMI With Cardiogenic Shock and RV Failure: Escalating to ECMO for Hemodynamic Rescue 02:55 81 Comprehensive Invasive Physiology Suite: From Diagnosis to Outcomes 10:20 82 STEMI vs. Cardiogenic Shock: Understanding the Data on Complete vs. Culprit-Only PCI 13:07 83 Expanding Indication for Intravascular Lithotripsy 14:50 84 Restore EF, Protect III, Protect IV: Where Is the Data Leading? 09:00 85 Shock Outcomes in 2024: Review of Recent Data and Where to Go from There 14:45 86 Acute Cardiogenic Shock Management 10:17 87 STEMI Management: Unloading Before Revascularization – Clinical Implications 10:53 88 Elective Multivessel CAD and the Evidence for Complete Revascularization 09:50
